Patent · US Active

Antibody molecules which bind IL-17A and IL-17F

US8303953B2 · kind B2 · utility

13Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 18, 2007
Grant dateNov 6, 2012
Priority date
Expiry dateMar 2, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.